| Cefixime |
Tablet (Chewable) |
II (Paddle |
25 |
Phosphate Buffer, pH 7.2 |
900 |
10, 15, 20, 30, and 45 |
2010/12/23 |
| Cefixime |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Cefixime |
Capsule |
I (Basket) |
100 |
0.05 M Phosphate Buffer, pH 7.2 |
900 |
10, 20, 30, 45 and 60 |
2013/08/15 |
| Cefixime |
Suspension |
II (Paddle) |
50 |
0.05 M Phosphate buffer, pH 7.2 |
900 |
10, 20, 30 and 45 |
2007/04/09 |
| Cefpodoxime Proxetil |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
| Cefpodoxime Proxetil |
Suspension |
II (Paddle) |
50 |
Glycine Buffer (0.04 M) pH 3.0 |
900 |
10, 20, 30 and 45 |
2005/12/20 |
| Cefprozil |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Cefprozil |
For Oral Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Cefprozil Monohydrate |
Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Ceftibuten Dihydrate |
Suspension |
II (Paddle) |
50 |
0.05 M Phosphate Buffer, pH 7.0 |
1000 |
10, 20, 30 and 45 |
2004/01/21 |
| Cefuroxime Axetil |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
| Celecoxib |
Capsule |
II (Paddle) |
50 mg, 100 mg and 200 mg: 50 rpm; 400 mg: 75 rpm |
Tier 1 Medium: 0.04 M tribasic sodium phosphate (pH 12) with 1% SLS. Tier 2 Initial Medium: 750 mL of simulated gastric fluid, USP (includes pepsin); At 20 minutes, while stirring, add 180 mL of appropriate concentrations of SLS solution (for a final concentration of 1% SLS). Add about 70 mL of 1.2 N NaOH to adjust the pH to 12. |
Tier 1: 1000 mL Tier 2: 750 mL (initial) 1000 mL (final) |
10, 20, 30, 45 and 60 |
2010/07/01 |
| Celecoxib; Tramadol HCl |
Tablet |
II (Paddle) |
75 |
0.1N Hydrochloric Acid + 2% SLS |
1000 |
5, 10, 15, 20, 30, 45 and 60 |
2023/07/07 |
| Celocoxib |
Suspension |
II (Paddle) |
75 |
40 mM Sodium Phosphate Tribasic Buffer, pH 11.1 with 0.5% SDS |
1000 |
5, 10, 15, 20, 30, 45 and 60 |
2026/03/25 |
| Cenobamate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2024/08/05 |
| Cephalexin |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Cephalexin |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2026/03/25 |
| Cephalexin |
Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Ceritinib |
Tablet |
I (Basket) |
75 |
0.01 N HCl (degassed) |
900 |
5, 10, 15, 20 and 30 |
2021/04/22 |
| Ceritinib |
Capsule |
II (Paddle) |
60 |
0.01 N HCl (degassed) |
900 |
5, 10, 15, 20 and 30 |
2015/08/27 |